121 related articles for article (PubMed ID: 34973279)
1. Level Ib sparing intensity-modulated radiation therapy in selected nasopharyngeal carcinoma patients based on the International Guideline.
Guo Q; Xiao N; Xu H; Zong J; Xiao Y; Lu T; Xu Y; Wang B; Chen B; Pan J; Lin S
Radiother Oncol; 2022 Feb; 167():239-243. PubMed ID: 34973279
[TBL] [Abstract][Full Text] [Related]
2. The feasibility of level Ib-sparing intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma and high-risk factors classified based on the International Guideline.
Meng Z; Li P; Yang D; Huang H; Dong H; Qin Y; Bin Y; Li R; Wang S; Chen X; Kang M
Radiother Oncol; 2024 Feb; 191():110027. PubMed ID: 38008418
[TBL] [Abstract][Full Text] [Related]
3. Neck level Ib-sparing versus level Ib-irradiation in intensity-modulated radiotherapy for the treatment of nasopharyngeal carcinoma with high-risk factors: A propensity score-matched cohort study.
Wang G; Huang C; Yang K; Guo R; Qiu Y; Li W; Mao Y; Tang L; Ma J
Radiother Oncol; 2022 Dec; 177():205-213. PubMed ID: 36375564
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis.
Zhang F; Cheng YK; Li WF; Guo R; Chen L; Sun Y; Mao YP; Zhou GQ; Liu X; Liu LZ; Lin AH; Tang LL; Ma J
BMC Cancer; 2015 Oct; 15():709. PubMed ID: 26472233
[TBL] [Abstract][Full Text] [Related]
5. Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study.
Guo Q; Lu T; Huang W; Xu H; Zhang Q; Xiao Y; Zhong J; Xie H; Chen J; Zong J; Gong X; Pan J; Li J; Lin S
Radiother Oncol; 2024 Mar; 192():110086. PubMed ID: 38184146
[TBL] [Abstract][Full Text] [Related]
6. Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.
Chen J; Ou D; He X; Hu C
Int J Clin Oncol; 2014 Dec; 19(6):998-1004. PubMed ID: 24337503
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma.
Zeng L; Zhang Q; Ao F; Jiang CL; Xiao Y; Xie HH; Tang YQ; Gong XC; Li JG
Auris Nasus Larynx; 2019 Jun; 46(3):457-464. PubMed ID: 30528104
[TBL] [Abstract][Full Text] [Related]
8. Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study.
Li M; Huang XG; Yang ZN; Lu JY; Zhan YZ; Xie WJ; Zhou DJ; Wang L; Zhu DX; Lin ZX
Br J Radiol; 2016 Sep; 89(1065):20150621. PubMed ID: 27376590
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of intensity-modulated radiotherapy versus two-dimensional conventional radiotherapy in locally advanced nasopharyngeal carcinoma: Comparative study at SKIMS Tertiary Care Institute.
Fatima K; Andleeb A; Sofi MA; Rasool MT; Fir A; Nasreen S; Dar NA
J Cancer Res Ther; 2022; 18(1):133-139. PubMed ID: 35381774
[TBL] [Abstract][Full Text] [Related]
10. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low-risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels.
Ou X; Miao Y; Wang X; Ding J; He X; Hu C
Radiat Oncol; 2017 Aug; 12(1):137. PubMed ID: 28821277
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes of replanning during intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma: An updated and expanded retrospective analysis.
Zhou X; Wang W; Zhou C; Zhu J; Ding W; Chen M; Chen K; Shi Y; Chen X; Kong FM; Yang H
Radiother Oncol; 2022 May; 170():136-142. PubMed ID: 35288229
[TBL] [Abstract][Full Text] [Related]
12. Distribution of regional lymph lode metastasis in unilateral nasopharyngeal carcinoma and the suggestions for selective prophylactic irradiation with intensity-modulated radiotherapy.
Lin F; Qiu Z; Xie D; Zhou X; Wang L; Wu Z; Cheng W; Lyu S; Su Y; Tao Y
Cancer Med; 2023 Nov; 12(21):20511-20520. PubMed ID: 37881136
[TBL] [Abstract][Full Text] [Related]
13. Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity-modulated radiotherapy.
Xiao XT; Wu YS; Chen YP; Liu X; Guo R; Tang LL; Ma J; Li WF
Cancer Med; 2023 Jan; 12(2):1399-1408. PubMed ID: 35822664
[TBL] [Abstract][Full Text] [Related]
14. Advantages of using reduced-volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study.
Liu F; Luo T; Jin T; Zhang J; Xiang Z; Yan R; Xie L; Wu X; Zhang H; Wang F; Li P; Liu L
BMC Cancer; 2019 Jun; 19(1):554. PubMed ID: 31176358
[TBL] [Abstract][Full Text] [Related]
15. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
16. Modified reduced-volume intensity-modulated radiation therapy in non-metastatic nasopharyngeal carcinoma: A prospective observation series.
Guo Q; Zheng Y; Lin J; Xu Y; Hu C; Zong J; Lu T; Xu H; Chen B; Liang Q; Xiao Y; Pan J; Lin S
Radiother Oncol; 2021 Mar; 156():251-257. PubMed ID: 33418007
[TBL] [Abstract][Full Text] [Related]
17. Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
Poon DMC; Kam MKM; Johnson D; Mo F; Tong M; Chan ATC
Head Neck; 2021 Jun; 43(6):1711-1720. PubMed ID: 33576030
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities.
Sun X; Su S; Chen C; Han F; Zhao C; Xiao W; Deng X; Huang S; Lin C; Lu T
Radiother Oncol; 2014 Mar; 110(3):398-403. PubMed ID: 24231245
[TBL] [Abstract][Full Text] [Related]
19. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of gross tumor regression and plasma Epstein Barr Virus DNA levels at the end of intensity-modulated radiation therapy in patients with nasopharyngeal carcinoma.
Liang SB; Zhang N; Chen DM; Yang XL; Chen BH; Zhao H; Lu RL; Chen Y; Fu LW
Radiother Oncol; 2019 Mar; 132():223-229. PubMed ID: 30366725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
